BARCELONA, Spain, December 14, 2011 /PRNewswire/ -- The Contract Research Organization Kymos Pharma Services -specialised in analysis for the pharmaceutical, fine chemicals,

LAGUNA NIGUEL, Calif., Oct. 3, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc.

OSLO, Norway, September 27, 2011 /PRNewswire/ -- - Strategic collaboration with Ipsen for marketing rights in Europe and the rest of the world

ST. LOUIS, Dec. 6, 2010 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) announced today the appointment of Laura K. Ipsen to the company's Board of Directors.

PARIS and LAUSANNE, Switzerland, February 4 /PRNewswire/ -- Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.